Open Access

[Retracted] Anti‑Semaphorin‑7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury

  • Authors:
    • Xiao Chen
    • Hailing Wang
    • Kui Jia
    • Hao Wang
    • Tao Ren
  • View Affiliations

  • Published online on: August 14, 2023     https://doi.org/10.3892/etm.2023.12165
  • Article Number: 466
  • Copyright : © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

October-2023
Volume 26 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen X, Wang H, Jia K, Wang H and Ren T: [Retracted] Anti‑Semaphorin‑7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury. Exp Ther Med 26: 466, 2023
APA
Chen, X., Wang, H., Jia, K., Wang, H., & Ren, T. (2023). [Retracted] Anti‑Semaphorin‑7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury. Experimental and Therapeutic Medicine, 26, 466. https://doi.org/10.3892/etm.2023.12165
MLA
Chen, X., Wang, H., Jia, K., Wang, H., Ren, T."[Retracted] Anti‑Semaphorin‑7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury". Experimental and Therapeutic Medicine 26.4 (2023): 466.
Chicago
Chen, X., Wang, H., Jia, K., Wang, H., Ren, T."[Retracted] Anti‑Semaphorin‑7A single chain antibody demonstrates beneficial effects on pulmonary inflammation during acute lung injury". Experimental and Therapeutic Medicine 26, no. 4 (2023): 466. https://doi.org/10.3892/etm.2023.12165